Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 21 15630 78731 94033 351--
Entreprise Value (EV)1 29 55238 39039 26439 58038 00136 623
P/E ratio -55,8x27,4x-230x31,5x25,6x22,2x
Yield 0,93%0,64%0,62%0,60%0,63%0,63%
Capitalization / Revenue 2,67x3,86x4,55x4,11x3,91x3,77x
EV / Revenue 3,73x4,81x5,59x4,88x4,46x4,14x
EV / EBITDA 11,1x14,7x19,2x14,9x13,1x12,0x
Price to Book 1,88x2,49x2,62x2,29x2,12x1,95x
Nbr of stocks (in thousands) 203 976205 684207 278208 482--
Reference price (USD) 104150154160160160
Announcement Date 02/01/201902/04/202002/05/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 7 9337 9827 0258 1158 5208 849
EBITDA1 2 6552 6102 0442 6632 9113 055
Operating profit (EBIT)1 2 2102 1891 6092 1822 4102 597
Operating Margin 27,9%27,4%22,9%26,9%28,3%29,3%
Pre-Tax Profit (EBT)1 -271906-2741 3731 5912 161
Net income1 -3791 132-1391 0631 3151 522
Net margin -4,78%14,2%-1,98%13,1%15,4%17,2%
EPS2 -1,865,47-0,675,076,257,20
Dividend per Share2 0,960,960,960,961,001,01
Announcement Date 02/01/201902/04/202002/05/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 1 9292 0851 8471 9782 0252 271
EBITDA1 617682590646662765
Operating profit (EBIT)1 508565476522544650
Operating Margin 26,3%27,1%25,8%26,4%26,9%28,6%
Pre-Tax Profit (EBT)1 256196221254263375
Net income1 243334198230249335
Net margin 12,6%16,0%10,7%11,6%12,3%14,7%
EPS2 1,161,590,941,121,231,62
Dividend per Share ------
Announcement Date 11/06/202002/05/202105/04/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 8 3967 6047 3246 2294 6503 273
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,16x2,91x3,58x2,34x1,60x1,07x
Free Cash Flow1 1 3081 0637958681 6631 925
ROE (Net Profit / Equities) 13,6%13,7%9,61%11,6%11,7%12,3%
Shareholders' equity1 -2 7878 234-1 4459 18911 23312 384
ROA (Net Profit / Asset) 6,24%6,67%4,82%6,31%7,07%7,78%
Assets1 -6 07316 965-2 88316 82818 61119 570
Book Value Per Share2 55,360,158,769,875,682,1
Cash Flow per Share2 8,597,675,829,3011,312,7
Capex1 439523409473498500
Capex / Sales 5,53%6,55%5,83%5,83%5,85%5,65%
Announcement Date 02/01/201902/04/202002/05/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 33 350 881 696
Net sales (USD) 7 024 500 000
Number of employees 20 000
Sales / Employee (USD) 351 225
Free-Float 66,7%
Free-Float capitalization (USD) 22 246 700 779
Avg. Exchange 20 sessions (USD) 204 178 541
Average Daily Capital Traded 0,61%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA